IV nutrition therapy is commonly used in medical settings but is gaining popularity in wellness circles. Learn the potential ...

Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.

Therapy and Vein Access Market. Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Therapy and Vein Access Market" report has been added to Research ...

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

The IV infusion form of Entyvio comes in a strength ... If you’re starting therapy with Entyvio, you may have questions about the medication. Here are some commonly asked questions and answers.

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...

Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging ...